RT期刊文章SR电子T1预测SARS-CoV-2引起的COVID-19肺炎患者的死亡率:前瞻性群组研究摩根富林明欧洲呼吸杂志乔和J FD欧元欧洲呼吸学会SP 2000524 10.1183/13993003.00524 -2020签证官55是5188bet官网地址 A1 Du, Rong-Hui A1梁,李蓉A1杨,温家宝A1曹,A1 cheng qing Wang Tan-Ze A1 Li Ming A1郭,Guang-Yun A1 Du,胡安A1郑,chun lan A1朱,气A1,明A1, Xu-Yan A1彭,彭A1史,摘要本研究的目的是寻找与新型冠状病毒SARS-CoV-2引起的COVID-19肺炎患者死亡相关的因素。所有临床和实验室参数前瞻性收集自2019年12月25日至2020年2月7日在武汉市肺医院住院的COVID-19肺炎患者队列。采用单因素logistic回归和多因素logistic回归分析各变量与COVID-19肺炎患者死亡风险的关系。本次前瞻性研究共纳入179例COVID-19肺炎患者(男性97例，女性82例)，其中死亡21例。单因素和多因素logistic回归分析显示，年龄≥65岁(OR 3.765, 95% CI 1.201-11.803;(p=0.023)，既存的心脑血管疾病(或2.464,95% CI 1.279-4.747;(p=0.007)， CD3+CD8+ t细胞≤75个细胞;心肌肌钙蛋白I≥0.05 ng·mL−1(或4.077,95% CI 1.778-9.349;p<0.001)与COVID-19肺炎死亡风险增加有关。 In a sex-, age- and comorbid illness-matched case–control study, CD3+CD8+ T-cells ≤75 cells·μL−1 and cardiac troponin I ≥0.05 ng·mL−1 remained as predictors for high mortality from COVID-19 pneumonia.We identified four risk factors: age ≥65 years, pre-existing concurrent cardiovascular or cerebrovascular diseases, CD3+CD8+ T-cells ≤75 cells·μL−1 and cardiac troponin I ≥0.05 ng·mL−1. The latter two factors, especially, were predictors for mortality of COVID-19 pneumonia patients.These data showed that age ≥65 years, pre-existing concurrent cardiovascular or cerebrovascular diseases, CD3+CD8+ T-cells ≤75 cells·μL−1 and cardiac troponin I ≥0.05 ng·mL−1 were four risk factors predicting high mortality of COVID-19 pneumonia patients https://bit.ly/2Rh6Nqv